Cadence Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 1, 2025	Reprieve Cardiovascular	$61.0M Series B	David Neustaedter	Arboretum Ventures, Lightstone Ventures, Hanson S. Gifford, Genesis Capital, Anita Watkins, Sante Ventures

Total Raised

N/A

Valuation

N/A